CSL has always been run like a high growth tech company rather than a pharmaceutical company. It used cheap loans to constantly make acquisitions and buybacks..The result is a mountain of debt, very little cash and a share price 50-80% too high.
“Only when the tide goes out do you learn who has been swimming naked.”
- Warren Buffett.
CSL has always been run like a high growth tech company rather...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$277.63 |
Change
-0.270(0.10%) |
Mkt cap ! $134.1B | |||
| Open | High | Low | Value | Volume |
| $277.94 | $279.11 | $276.35 | $217.1M | 783.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 315 | $277.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $277.63 | 49 | 1 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$277.63 |
Change
-0.270 ( 0.34 %) |
||||
| Open | High | Low | Volume | ||
| $278.97 | $278.97 | $276.36 | 25608 | ||
| Last updated 16.10pm 21/05/2024 ? | |||||
| CSL (ASX) Chart |